# EROSION II: OCT Guided PPCI in STEMI

> **NCT03062826** · — · UNKNOWN · sponsor: **Harbin Medical University** · enrollment: 347 (actual)

## Conditions studied

- ST-segment Elevation Myocardial Infarction

## Interventions

- **DRUG:** dual antiplatelet therapy (aspirin + ticagrelor or aspirin + clopidogrel)

## Key facts

- **NCT ID:** NCT03062826
- **Lead sponsor:** Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-11
- **Primary completion:** 2022-02-24
- **Final completion:** 2023-03-01
- **Target enrollment:** 347 (ACTUAL)
- **Last updated:** 2022-06-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062826, "EROSION II: OCT Guided PPCI in STEMI". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03062826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*